<?xml version="1.0" encoding="UTF-8"?><bill xmlns="http://schemas.gpo.gov/xml/uslm" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://schemas.gpo.gov/xml/uslm uslm-2.0.10.xsd" xml:lang="en"><meta><dc:title>117 S. 578 ENR: To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.</dc:title><dc:type>Senate Bill</dc:type><dc:creator>U.S. Senate</dc:creator><congress>117</congress><session>1</session><docNumber>578</docNumber><docStage>ENR</docStage><citableAs>117s578enr</citableAs><citableAs>117 S. 578 ENR</citableAs><dc:format>text/xml</dc:format><dc:language>EN</dc:language><dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights><processedBy>Xcential BillDTD to USLM Converter v20210601</processedBy><processedDate>2021-11-20</processedDate><publicPrivate>public</publicPrivate></meta><preface><dc:type>S. </dc:type><docNumber>578</docNumber><congress value="117">One Hundred Seventeenth Congress of the United States of America</congress><session value="1">AT THE FIRST SESSION</session><enrolledDateline>Begun and held at the City of Washington on Sunday, the third day of January, two thousand and twenty one</enrolledDateline></preface><main id="HE79711B349CB11EC890209173F13E4C5"><longTitle><docTitle>AN ACT</docTitle><officialTitle>To improve the health and safety of Americans living with food allergies and related disorders, including potentially life-threatening anaphylaxis, food protein-induced enterocolitis syndrome, and eosinophilic gastrointestinal diseases, and for other purposes.</officialTitle></longTitle><enactingFormula>Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,</enactingFormula><section identifier="/s1" id="id854918dc3b5f42429b623e0eae6dc147" class="bill-dtd-OLC"><num value="1">SECTION 1.</num><heading> SHORT TITLE.</heading><content class="indent0">This Act may be cited as the “<shortTitle>Food Allergy Safety, Treatment, Education, and Research Act of 2021</shortTitle>” or the “<shortTitle>FASTER Act of 2021</shortTitle>”.</content></section><section identifier="/s2" id="id1f194347d537486f9e1626de2155acc2" class="bill-dtd-OLC"><num value="2">SEC. 2.</num><heading> FOOD ALLERGY SAFETY.</heading><subsection identifier="/s2/a" id="idc3ae7b9e438c4530a6d073c186eed737" class="bill-dtd-OLC"><num value="a">(a)</num><heading> In General.—</heading><content>Section 201(qq)(1) of the Federal Food, Drug, and Cosmetic Act (<ref href="/us/usc/21/321">21 U.S.C. 321(qq)(1)</ref>) is amended by striking “<quotedText>and soybeans</quotedText>” and inserting “<quotedText>soybeans, and sesame</quotedText>”. </content></subsection><subsection identifier="/s2/b" id="id75daeca9a6974010b2f6fa7a42884057" class="bill-dtd-OLC"><num value="b">(b)</num><heading> Effective Date.—</heading><content>The amendment made by subsection (a) shall apply to any food that is introduced or delivered for introduction into interstate commerce on or after January 1, 2023.</content></subsection></section><section identifier="/s3" id="id667777b98a304eb1afa0484951c0f75d" class="bill-dtd-OLC"><num value="3">SEC. 3.</num><heading> REPORT TO CONGRESS.</heading><subsection identifier="/s3/a" id="idacde368d971a472091ff1b084b7b0f90" class="bill-dtd-OLC"><num value="a">(a)</num><heading> Report.—</heading><chapeau>Not later than 18 months after the date of enactment of this Act, the Secretary of Health and Human Services (referred to in this section as the “<quotedText>Secretary</quotedText>”) shall submit to the Committee on Health, Education, Labor, and Pensions of the Senate and the Committee on Energy and Commerce of the House of Representatives a report that includes—</chapeau><paragraph identifier="/s3/a/1" id="id735c8686a3f643da83977dd48cfbc56e" class="bill-dtd-OLC"><num value="1">(1)</num><chapeau> descriptions of ongoing Federal activities related to—</chapeau><subparagraph identifier="/s3/a/1/A" id="id07a9cdcea59a4682b9d3a34578d05197" class="bill-dtd-OLC"><num value="A">(A)</num><content> the surveillance and collection of data on the prevalence of food allergies and severity of allergic reactions for specific food or food ingredients, including the identification of any gaps in such activities;</content></subparagraph><subparagraph identifier="/s3/a/1/B" id="id2d465ce24b6249ee8d88b76c57421758" class="bill-dtd-OLC"><num value="B">(B)</num><content> the development of effective food allergy diagnostics;</content></subparagraph><subparagraph identifier="/s3/a/1/C" id="id43379cfc3c2b4695b03aff1b41b61984" class="bill-dtd-OLC"><num value="C">(C)</num><content> the prevention of the onset of food allergies;</content></subparagraph><subparagraph identifier="/s3/a/1/D" id="id811bbf1394b945f1add2cddfae395aaa" class="bill-dtd-OLC"><num value="D">(D)</num><content> the reduction of risks related to living with food allergies; and</content></subparagraph><subparagraph identifier="/s3/a/1/E" id="id46cf0781c10e46fbadd3faf97cec71d9" class="bill-dtd-OLC"><num value="E">(E)</num><content> the development of new therapeutics to prevent, treat, cure, and manage food allergies; and</content></subparagraph></paragraph><paragraph identifier="/s3/a/2" id="idfcb91ef117ff4207936eb6207e5d0a57" class="bill-dtd-OLC"><num value="2">(2)</num><chapeau> specific recommendations and strategies to expand, enhance, or improve activities described in paragraph (1), including—</chapeau><subparagraph identifier="/s3/a/2/A" id="idd07513a10e494260a9ade2c0f4da862b" class="bill-dtd-OLC"><num value="A">(A)</num><content> strategies to improve the accuracy of food allergy prevalence data by expanding and intensifying current collection methods, including support for research that includes the identification of biomarkers and tests to validate survey data and the investigation of the use of identified biomarkers and tests in national surveys;</content></subparagraph><subparagraph identifier="/s3/a/2/B" id="id41a6717b2df44ee88a1d986b544ea3eb" class="bill-dtd-OLC"><num value="B">(B)</num><content> strategies to overcome gaps in surveillance and data collection activities related to food allergies and specific food allergens; and</content></subparagraph><subparagraph identifier="/s3/a/2/C" id="idf3bb8bb1e47c4e7987f80140f7a39cc0" class="bill-dtd-OLC"><num value="C">(C)</num><chapeau> recommendations for the development and implementation of a regulatory process and framework that would allow for the timely, transparent, and evidence-based modification of the definition of “<quotedText>major food allergen</quotedText>” included in section 201(qq) of the Federal Food, Drug and Cosmetic Act (<ref href="/us/usc/21/321">21 U.S.C. 321(qq)</ref>), including with respect to—</chapeau><clause identifier="/s3/a/2/C/i" id="idE1A03C0294B242F8B87CE34A3A82A018" class="bill-dtd-OLC"><num value="i">(i)</num><content> the scientific criteria for defining a food or food ingredient as a “<quotedText>major food allergen</quotedText>” pursuant to such process, including recommendations pertaining to evidence of the prevalence and severity of allergic reactions to a food or food ingredient that would be required in order to establish that such food or food ingredient is an allergen of public health concern appropriate for such process; and</content></clause><clause identifier="/s3/a/2/C/ii" id="id884894630B7C45C2A01D93C6451B2CC4" class="bill-dtd-OLC"><num value="ii">(ii)</num><content> opportunities for stakeholder engagement and comment, as appropriate, in considering any such modification to such definition.</content></clause></subparagraph></paragraph></subsection><subsection identifier="/s3/b" id="idcd37bc5fc10d46d9979edfb9f76e5826" class="bill-dtd-OLC"><num value="b">(b)</num><heading> Publication.—</heading><content>The Secretary shall make the report under subsection (a) available on the internet website of the Department of Health and Human Services.</content></subsection></section></main><signatures><signature><name/><role>Speaker of the House of Representatives</role></signature><signature><name/><role>Vice President of the United States and President of the Senate</role></signature></signatures></bill>